"In vitro" activities of antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's disease and paratuberculosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

1. Vaccines · 2023
   Article
2. Rifabutin-Loaded Nanostructured Lipid Carriers as a Tool in Oral Anti-Mycobacterial Treatment of Crohn's Disease.Nanomaterials (Basel, Switzerland) · 2020
   Article
3. Profound remission in Crohn's disease requiring no further treatment for 3-23 years: a case series.Gut pathogens · 2020
   Article
4. Antibiotics in inflammatory bowel diseases: do we know what we're doing?Translational pediatrics · 2019
   Review
5. RHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn's disease associated with Mycobacterium paratuberculosis.Gut pathogens · 2016
   Article
6. Optimization of a rapid viability assay for Mycobacterium avium subsp. paratuberculosis by using alamarBlue.Applied and environmental microbiology · 2009
   Article
7. Antibacterial activities of naturally occurring compounds against Mycobacterium avium subsp. paratuberculosis.Applied and environmental microbiology · 2008
   Article
8. On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease.PloS one · 2008
   Article
9. Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro.Antimicrobial agents and chemotherapy · 2008
   Article
10. On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis.PloS one · 2007
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors at 2 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as